脂肝合剂联合多烯磷脂酰胆碱胶囊治疗非酒精性脂肪性肝病临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R575

基金项目:


Clinical Study on Zhigan Mixture Combined with Polyene Phosphatidylcholine Capsules for Non-alcoholic Fatty Liver Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察脂肝合剂联合多烯磷脂酰胆碱胶囊治疗痰湿内阻型非酒精性脂肪性肝病(NAFLD) 的 临床疗效。方法:选取76 例痰湿内阻型NAFLD 患者,按随机数字表法分为对照组与治疗组各38 例,对照组 剔除1 例,治疗组剔除4 例,最终纳入研究对照组37 例,治疗组34 例。2 组均给予饮食控制加适量锻炼,对 照组在此基础上给予多烯磷脂酰胆碱胶囊治疗,治疗组给予脂肝合剂联合多烯磷脂酰胆碱胶囊治疗。2 组均治 疗8 周。比较2 组临床疗效、中医证候积分、肝功能指标[谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰 转肽酶(GGT)]、血脂指标[甘油三酯(TG)、总胆固醇(TC)]、受控衰减参数(CAP) 及肝/脾CT 比值。 结果:治疗后,治疗组总有效率91.18%,高于对照组72.97% (P<0.05)。2 组中医证候积分均较治疗前降 低(P<0.05),治疗组中医证候积分低于对照组(P<0.05)。2 组血清ALT、AST、GGT、TG、TC 水平均较治 疗前降低(P<0.05),治疗组血清ALT、AST、GGT、TG、TC 水平均低于对照组(P<0.05)。2 组CAP 均较 治疗前降低(P<0.05),肝/脾CT 比值均较治疗前升高(P<0.05);治疗组CAP 低于对照组(P<0.05),肝/ 脾CT 比值高于对照组(P<0.05)。结论:脂肝合剂联合多烯磷脂酰胆碱胶囊治疗痰湿内阻型NAFLD,可有效 缓解临床症状,调节肝功能和血脂指标,减轻肝脏脂肪变性程度。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Zhigan Mixture combined with Polyene Phosphatidylcholine Capsules for non- alcoholic fatty liver disease (NAFLD) of internal obstruction of phlegm- damp type. Methods: A total of 76 cases of NAFLD patients of internal obstruction of phlegmdamp type were selected and divided into the control group and the treatment group according to the random number table method,with 38 cases in each group;1 case was excluded from the control group, 4 cases were excluded from the treatment group,and ultimately 37 cases in the control group and 34 cases in the treatment group were included. Both groups were given dietary control and moderate exercise;the control group was additionally treated with Polyene Phosphatidylcholine Capsules,and the treatment group was treated with Zhigan Mixture combined with Polyene Phosphatidylcholine Capsules. Both groups were treated for 8 weeks. The clinical effects, traditional Chinese medicine (TCM) syndrome scores, liver function indicators [alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ- glutamyl transpeptidase (GGT)], blood lipid indicators [triglycerides (TG) and total cholesterol (TC)], controlled attenuation parameters (CAP), and CT- based liver- to- spleen ratio were compared between the two groups before and after treatment. Results: After treatment, the total effective rate was 91.18% in the treatment group,higher than that of 72.97% in the control group (P<0.05). The TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05),and the score in the treatment group was lower than that in the control group (P<0.05). The levels of ALT, AST, GGT, TG,and TC in serum in the two groups were decreased when compared with those before treatment (P< 0.05), and the levels of ALT, AST, GGT, TG and TC in serum in the treatment group were lower than those in the control group (P<0.05). The CAP in the two groups were decreased when compared with those before treatment (P<0.05), and CT- based liver- to- spleen ratios were increased when compared with those before treatment (P<0.05);CAP in the treatment group was lower than that in the control group (P< 0.05),and CT-based liver-to-spleen ratio in the treatment group was higher than that in the control group (P<0.05). Conclusion:Zhigan Mixture combined with Polyene Phosphatidylcholine Capsules for NAFLD of internal obstruction of phlegm- damp type can effectively relieve clinical symptoms, regulate the liver function and blood lipid indicators,and reduce the degree of liver steatosis.

    参考文献
    相似文献
    引证文献
引用本文

刘三海,陈靓,金若珏,叶小丹,胡倩倩,朱小区.脂肝合剂联合多烯磷脂酰胆碱胶囊治疗非酒精性脂肪性肝病临床研究[J].新中医,2024,56(2):74-78

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-01-25
  • 出版日期: